Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 11, 2001, Pages 1639-1644

  Begley, David ^a   Mohiddin, Saidi ^a   Fananapazir, Lameh ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hypertrophic cardiomyopathy; Mid cavity obstruction; Pacing

Indexed keywords

ATENOLOL; DILTIAZEM; DISOPYRAMIDE; DIURETIC AGENT; ENALAPRIL; SOTALOL; VERAPAMIL;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; EXERCISE TOLERANCE; FEMALE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE;

EID: 0035165517     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01639.x     Document Type: Article

References (42)

1. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
2. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy
3. Obstruction to left ventricular outflow. Current concepts of management and operative treatment
4. Operative treatment of hypertrophic obstructive cardiomyopathy. The case against mitral valve replacement
5. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis
6. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
7. Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy: Influence of associated mitral valve replacement
8. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results
9. Morrow septal myectomy for patients with HOCM
10. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
11. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
12. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy
13. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
14. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy
15. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy
16. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
17. DDD pacing in hypertrophic cardiomyopathy: A multicentre clinical experience
18. Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy
19. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study
20. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest
21. Mutations in either the essential or regulatory light chains cause a rare myopathy in human heart and skeletal muscle
22. Advances in molecular genetics and management of hypertrophic cardiomyopathy
23. Midventricular obstruction - A form of hypertrophic obstructive cardiomyopathy - And systolic anterior motion of the mitral valve
24. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: Higher incidence in patients with midventricular obstruction
25. The management of hypertrophic cardiomyopathy
26. Hypertrophic cardiomyopathy: Place and limitations of medical therapy
27. Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy
28. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echocardiographic study
29. Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil
30. Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy
31. Combination of disopyramide and propranolol in hypertrophic cardiomyopathy
32. Relief of left ventricular outflow tract obstruction following inadvertent left ventricular apical pacing in a patient with hypertrophic cardiomyopathy
33. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular apical aneurysm
34. Apical hypertrophic cardiomyopathy presenting with sustained monomorphic ventricular tachycardia and electrocardiographic changes simulating coronary artery disease and left ventricular aneurysm
35. Apical sequestration in hypertrophic cardiomyopathy: Its clinical features and pathophysiology
36. Hypertrophic cardiomyopathy with apical aneurysm: Case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia
37. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
38. Obstructive hypertrophic cardiomyopathy: Therapeutic options
39. Therapeutic options in patients with obstructive HCM and severe drug-refractory symptoms
40. Dual chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
41. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, cross-over study (M-PATHY)
42. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow up